Cleared Traditional

K173648 - Spectralis HRA + OCT and variants (FDA 510(k) Clearance)

Aug 2018
Decision
276d
Days
Class 2
Risk

K173648 is an FDA 510(k) clearance for the Spectralis HRA + OCT and variants. This device is classified as a Tomography, Optical Coherence (Class II - Special Controls, product code OBO).

Submitted by Heidelberg Engineering GmbH (Heidelberg, DE). The FDA issued a Cleared decision on August 30, 2018, 276 days after receiving the submission on November 27, 2017.

This device falls under the Ophthalmic FDA review panel. Regulated under 21 CFR 886.1570. Viewing, Imaging, Measurement, And Analysis Of Ocular Structures. Diagnostic Device To Aid In The Detection And Management Of Various Ocular Diseases..

Submission Details

510(k) Number K173648 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 27, 2017
Decision Date August 30, 2018
Days to Decision 276 days
Submission Type Traditional
Review Panel Ophthalmic (OP)
Summary Summary PDF

Device Classification

Product Code OBO - Tomography, Optical Coherence
Device Class Class II - Special Controls
CFR Regulation 21 CFR 886.1570
Definition Viewing, Imaging, Measurement, And Analysis Of Ocular Structures. Diagnostic Device To Aid In The Detection And Management Of Various Ocular Diseases.